StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$83.26−1.60 (-1.89%)

Close on Nov 18, 2026Market cap $20.92BP/E –Yield –

BioNTech net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -€1.14B. The highest annual figure on record is €10.29B in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€1.14B–
FY2024Dec 31, 2024-€665.30M-171.5%
FY2023Dec 31, 2023€930.30M-90.1%
FY2022Dec 31, 2022€9.43B-8.3%
FY2021Dec 31, 2021€10.29B+67613.8%
FY2020Dec 31, 2020€15.20M–
FY2019Dec 31, 2019-€179.10M–
FY2018Dec 31, 2018-€48.02M–
FY2017Dec 31, 2017-€85.65M–

More BioNTech figures

See a number that looks wrong?